Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Melanie Cree, director of the University of Colorados PCOS multidisciplinary clinic and pediatric endocrinologist at Childrens Hospital Colorado, is the main investigator on a clinical trial testing semaglutide in 80 obese girls and women with PCOS aged 12 to 35
( 2 ) For people struggling with obesity or excess weight, these effects can lead to: Reduced appetite and cravings Eating smaller portion sizes without feeling deprived More stable blood sugar, which can help curb energy crashes A gradual, steady loss of body fat over time While GLP-1 medications were first approved for diabetes management, researchers soon noticed that many patients taking the medication experienced significant weight loss as a side effect
This is the closest approved option to retatrutide in terms of mechanism and results
Healthcare providers may also prescribe semaglutide or high-dose liraglutide for people who have overweight along with other health conditions if losing weight can help manage the coexisting conditions
2 Until CagriSema reaches the UK, Mounjaro and Wegovy remain the licensed options for adults with both type 2 diabetes and obesity who want a GLP-1 drug for weight management
A slightly yellow-tinted solution after reconstitution is also normal
